Skip to content

Methods and findings in experimental and clinical pharmacology

ISSN 0379-0355

3 papers in the library · 7 citations · publishing 2000-2007

Papers

Sort Most recent Most cited

Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.

Methods and findings in experimental and clinical pharmacology May 1, 2007 Takeshi Enomoto, Y Noda, Toshitaka Nabeshima

In humans, phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, reproduces a schizophrenia-like psychosis including positive symptoms, negative symptoms and cognitive dysfunction. Thus, PCP-treated animals have been utilized as an animal model of schizophrenia. PCP-treated animals exhibit hyperlocomotion as an index of positive symptoms, and a social behavioral...

Role of nitric oxide in experimental models of psychosis in rats.

Methods and findings in experimental and clinical pharmacology November 1, 2001 M Gupta, S Balakrishnan, P Pandhi

The aim of our study was to investigate the effects of the NO precursor L-arginine and the nitric oxide synthase inhibitor N omega-nitro-L-arginine (L-NORAG) on amphetamine-induced stereotypy, haloperidol-induced catalepsy and conditioned avoidance response (CAR) in rats. Amphetamine (3 mg/kg i.p.) was used for the induction of stereotypy, while for the induction of catalepsy and CAR,...

Pharmacokinetic characterization of the indole alkaloid ibogaine in rats.

Methods and findings in experimental and clinical pharmacology March 1, 2000 L B Hough, A A Bagal, Stanley D Glick 7 citations

To investigate the pharmacokinetic properties of ibogaine, a putatively anti-addictive alkaloid, levels of this drug were quantified in plasma and tissues for up to 3 h following i.v. infusion in rats. Immediately following a 31-35 min infusion (20 mg/kg), mean plasma ibogaine levels were 373 ng/ml; these values declined rapidly thereafter in a biexponential manner. The plasma time course in 5...